The slip
PARKINSON RECEIPTno. 3591
19 Oct 2026, 23:15 UTColigodendrocytes, braak
predictionNTRK3 in oligodendrocytes tracks Braak Lewy-body stage
registeredfb417b20b3370d17
discovery-0.22 p=0.565 n=9
replication+0.15 p=0.705 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.22, p 0.565)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT43321d707547f1cdef4fc080…
follows c7593e77fdaf…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 3591: NTRK3 in oligodendrocytes, braak
- power
- full sample -0.08 (p 0.767, n 18), 95% CI -0.52 to +0.41. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.07 (p 0.781, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.30 (p 0.232, n 18). could be the mix.
- skeptic
- leave-one-out range -0.17 to +0.04, sign flips 3; without severely affected donors -0.08 (p 0.767, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NTRK3 in oligodendrocytes.
case closed: nothing better to follow up.